Healthcare provider profile · identity verified

Neil P Smith, DO

Internal Medicine · FAIRVIEW PARK, OH · NPI 1861594038

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	573	128
Atorvastatin Calcium	Atorvastatin Calcium	486	127
Amlodipine Besylate	Amlodipine Besylate	483	105
Simvastatin	Simvastatin	390	84
Hydrochlorothiazide	Hydrochlorothiazide	289	73
Metformin Hcl	Metformin Hcl	268	69
Lisinopril	Lisinopril	219	51
Losartan Potassium	Losartan Potassium	210	51
Tamsulosin Hcl	Tamsulosin Hcl	207	55
Pantoprazole Sodium	Pantoprazole Sodium	188	56
Furosemide	Furosemide	183	53
Olmesartan Medoxomil	Olmesartan Medoxomil	180	45
Omeprazole	Omeprazole	173	45
Metoprolol Succinate	Metoprolol Succinate	167	46
Rosuvastatin Calcium	Rosuvastatin Calcium	158	43
Gabapentin	Gabapentin	145	34
Eliquis	Apixaban	137	25
Allopurinol	Allopurinol	134	34
Metoprolol Tartrate	Metoprolol Tartrate	126	36
Paroxetine Hcl	Paroxetine Hcl	125	30
Trazodone Hcl	Trazodone Hcl	114	25
Atenolol	Atenolol	107	28
Carvedilol	Carvedilol	105	18
Pravastatin Sodium	Pravastatin Sodium	93	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	18
Vitamin D2	Ergocalciferol (Vitamin D2)	81	21
Potassium Chloride	Potassium Chloride	79	20
Albuterol Sulfate Hfa	Albuterol Sulfate	78	32
Escitalopram Oxalate	Escitalopram Oxalate	73	16
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	73	17
Januvia	Sitagliptin Phosphate	72	17
Fenofibrate	Fenofibrate Nanocrystallized	70	11
Sertraline Hcl	Sertraline Hcl	69	18
Spironolactone	Spironolactone	69	13
Azithromycin	Azithromycin	63	55
Warfarin Sodium	Warfarin Sodium	60	14
Clopidogrel	Clopidogrel Bisulfate	59	23
Duloxetine Hcl	Duloxetine Hcl	54	13
Synthroid	Levothyroxine Sodium	53	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	suppressed
Buspirone Hcl	Buspirone Hcl	44	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Glipizide Er	Glipizide	39	suppressed
Propranolol Hcl Er	Propranolol Hcl	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Glipizide	Glipizide	33	suppressed
Alprazolam	Alprazolam	32	11
Methylprednisolone	Methylprednisolone	32	27
Ezetimibe	Ezetimibe	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	26
Meloxicam	Meloxicam	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Temazepam	Temazepam	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Colchicine	Colchicine	21	suppressed
Finasteride	Finasteride	21	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Ramipril	Ramipril	18	suppressed
Cephalexin	Cephalexin	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Torsemide	Torsemide	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Ethacrynic Acid	Ethacrynic Acid	13	suppressed
Indapamide	Indapamide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amiloride Hcl	Amiloride Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Prednisone	Prednisone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error